|
|
|
Insider
Information: |
Lloyd-Smith Malcolm |
Relationship: |
Chief Integration Offi... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
42,337 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,734,547 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
42,337 |
|
|
Total
Value |
$5,734,547 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cadence Pharmaceuticals Inc |
CADX |
SVP, Reg Affairs, Qual... |
2014-03-19 |
0 |
|
0 |
Premium* |
|
Neurocrine Biosciences Inc |
NBIX |
Chief Integration Offi... |
2023-02-08 |
42,337 |
2016-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2021-02-05 |
4 |
AS |
$114.15 |
$98,739 |
D/D |
(865) |
29,675 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2021-02-08 |
4 |
AS |
$116.74 |
$380,929 |
D/D |
(3,261) |
32,510 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2021-02-10 |
4 |
AS |
$119.95 |
$203,926 |
D/D |
(1,700) |
32,510 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2021-07-27 |
4 |
AS |
$93.80 |
$1,567,336 |
D/D |
(16,709) |
15,801 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2022-02-07 |
4 |
AS |
$80.65 |
$216,417 |
D/D |
(2,681) |
18,104 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2022-02-08 |
4 |
AS |
$79.53 |
$55,751 |
D/D |
(701) |
18,731 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2022-08-12 |
4 |
AS |
$105.95 |
$2,281,331 |
D/D |
(21,533) |
18,888 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Integration Officer |
|
2023-01-31 |
4 |
AS |
$110.02 |
$183,290 |
D/D |
(1,666) |
28,582 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Integration Officer |
|
2023-02-06 |
4 |
AS |
$105.82 |
$84,758 |
D/D |
(801) |
29,300 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Integration Officer |
|
2023-02-07 |
4 |
AS |
$102.16 |
$1,414,654 |
D/D |
(13,816) |
41,710 |
0 |
% |
|
NBIX |
Neurocrine Biosciences In... |
Chief Integration Officer |
|
2023-02-08 |
4 |
AS |
$103.83 |
$72,785 |
D/D |
(701) |
42,337 |
0 |
% |
|
CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & Clin |
|
2014-03-19 |
4 |
D |
$14.00 |
$32,648 |
D/D |
(2,332) |
0 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2018-02-06 |
4 |
D |
$82.48 |
$108,379 |
D/D |
(1,314) |
15,318 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & ClinO |
|
2012-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,332 |
|
- |
|
CADX |
Cadence Pharmaceuticals I... |
SVP, Reg Affairs, Qual & Clin |
|
2013-07-22 |
4 |
OE |
$3.51 |
$49,140 |
D/D |
14,000 |
16,332 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2016-05-31 |
4 |
OE |
$15.45 |
$139,050 |
D/D |
9,000 |
9,000 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2016-09-01 |
4 |
OE |
$15.45 |
$139,050 |
D/D |
9,000 |
9,000 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2017-05-18 |
4 |
OE |
$15.45 |
$76,941 |
D/D |
4,980 |
17,997 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2017-05-19 |
4 |
OE |
$15.45 |
$76,941 |
D/D |
4,980 |
17,997 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2018-01-02 |
4 |
OE |
$15.45 |
$279,398 |
D/D |
18,084 |
31,101 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2018-11-06 |
4 |
OE |
$15.45 |
$88,065 |
D/D |
5,700 |
21,018 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2018-11-07 |
4 |
OE |
$15.45 |
$50,985 |
D/D |
3,300 |
18,618 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2019-10-14 |
4 |
OE |
$15.45 |
$153,820 |
D/D |
9,956 |
29,569 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2020-02-10 |
4 |
OE |
$32.99 |
$1,728,147 |
D/D |
28,969 |
39,127 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Chief Regulatory Officer |
|
2021-01-25 |
4 |
OE |
$32.99 |
$605,470 |
D/D |
17,570 |
37,960 |
0 |
- |
|
54 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|